Division News

Rheumatic Diseases and Pregnancy: Should HCQ Dose Change in Pregnancy?

For women who take hydroxychloroquine (HCQ) to control rheumatic disease, research has shown that it’s best for mother and baby to continue the medicine during pregnancy. But should the dose be maintained, decreased, or increased? Stephen Balevic, MD, assistant professor of pediatrics and medicine (Rheumatology and Immunology), set out to investigate this question using data from the Duke Autoimmunity in Pregnancy registry. 

Rheumatic Diseases and Pregnancy: How do Outcomes Correlate to Patient-Reported Measures?

When a woman with rheumatic disease is pregnant, she may experience many symptoms--some from her underlying disease and some from pregnancy itself. Which of these symptoms signal increased risk for preterm delivery?

Nathaniel Harris, MD, PhD, an intern in the Duke internal medicine residency program, spent his third year of medical school, also at Duke, plumbing the DAP registry for insights into this question.

5 from Medicine accepted to ALICE leadership program

School of Medicine Office for Faculty Development has announced the next class in its ALICE program, a leadership development opportunity for mid-career women faculty in the School of Medicine. Five participants in the next class are from the Department of Medicine.